Research output per year
Research output per year
Personal profile
Education/Academic qualification
PhD, Doctor of Philosophy (PhD), Ben-Gurion University of the Negev
1 Oct 2017 → 1 Oct 2020
Award Date: 1 Oct 2020
Bachelor, Bachelor of Science (BSc) in Computer Science, Open University of Israel
1 Oct 2013 → 1 Oct 2016
Award Date: 1 Oct 2016
PhD, Medical Doctor (MD), Tel Aviv University
1 Oct 2005 → 1 Oct 2009
Award Date: 1 Jun 2010
Bachelor, Bachelor of Medical Sciences (B. Med. Sci), Tel Aviv University
1 Oct 2002 → 1 Oct 2005
Award Date: 1 Oct 2005
External positions
Post-Doctorate, Harvard University
1 Nov 2020 → 30 Oct 2021
Head of Epidemiology & Research, Clalit Research Institute
1 Nov 2016 → …
Fingerprint
Dive into the research topics where Noam Barda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Utility of early colonoscopy for acute lower gastrointestinal bleeding: a retrospective cohort study
Lahat, A., Klang, E., Rahman, N., Halabi, N., Avidan, B. & Barda, N., 1 Jan 2023, In: Therapeutic Advances in Gastroenterology. 16Research output: Contribution to journal › Article › peer-review
Open Access -
Association of opioid use disorder with healthcare utilization and cost in a public health system
Miron, O., Barda, N., Balicer, R., Kor, A. & Lev-Ran, S., 1 Nov 2022, In: Addiction.Research output: Contribution to journal › Article › peer-review
Open Access -
Association of Renin-Angiotensin-Aldosterone Inhibitors with COVID-19 Infection and Disease Severity among Individuals with Hypertension
Mahanaimy, M., Finkel, U., Barda, N., Roitman, E., Balicer, R., Senderey, A. B. & Feldman, B., 1 May 2022, In: Israel Medical Association Journal. 24, 5, p. 310-316 7 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age
Cohen-Stavi, C. J., Magen, O., Barda, N., Yaron, S., Peretz, A., Netzer, D., Giaquinto, C., Judd, A., Leibovici, L., Hernán, M. A., Lipsitch, M., Reis, B. Y., Balicer, R. D. & Dagan, N., 21 Jul 2022, In: New England Journal of Medicine. 387, 3, p. 227-236 10 p.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
Comparing COVID-19-related hospitalization rates among individuals with infection-induced and vaccine-induced immunity in Israel
Waxman, J. G., Makov-Assif, M., Reis, B. Y., Netzer, D., Balicer, R. D., Dagan, N. & Barda, N., 1 Dec 2022, In: Nature Communications. 13, 1, 2202.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Comparing immunogenicity and efficacy of two different mRNA-based COVID-19 vaccines as a fourth dose; six-month follow-up, Israel, 27 December 2021 to 24 July 2022
Barda, N., Canetti, M., Gilboa, M., Indenboim, V., Asraf, K., Weiss-Ottolenghi, Y., Amit, S., Zibly, D., Doolman, R., Mendelson, E., Harats, D., Freedman, L. S., Kreiss, Y., Lustig, Y. & Regev-Yochay, G., 1 Sep 2022, In: Eurosurveillance. 27, 39Research output: Contribution to journal › Article › peer-review
Open Access -
COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022
Kliker, L., Zuckerman, N., Atari, N., Barda, N., Gilboa, M., Nemet, I., Elkader, B. A., Fratty, I. S., Jaber, H., Mendelson, E., Alroy-Preis, S., Kreiss, Y., Regev-Yochay, G. & Mandelboim, M., 28 Jul 2022, In: Eurosurveillance. 27, 30Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI)
Katz, M. A., Harlev, E. B., Chazan, B., Chowers, M., Greenberg, D., Peretz, A., Tshori, S., Levy, J., Yacobi, M., Hirsch, A., Amichay, D., Weinberger, R., Dor, A. B., Taraday, E. K., Reznik, D., Chayat, C. B., Sagas, D., Zvi, H. B., Berdinstein, R., Rashid, G., & 9 others, 24 Jan 2022, In: Vaccine. 40, 3, p. 512-520 9 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Effectiveness of first-generation severe acute respiratory syndrome coronavirus 2 mRNA vaccines against the Omicron variant
Dagan, N. & Barda, N., 1 Jan 2022, (Accepted/In press) In: Clinical Microbiology and Infection. 28, 12, p. 1526-1527 2 p.Research output: Contribution to journal › Comment/debate
Open Access -
Effectiveness of REGEN-COV antibody combination in preventing severe COVID-19 outcomes
Hayek, S., Ben-shlomo, Y., Dagan, N., Reis, B. Y., Barda, N., Kepten, E., Roitman, A., Shapira, S., Yaron, S., Balicer, R. D., Netzer, D. & Peretz, A., 1 Dec 2022, In: Nature Communications. 13, 1, 4480.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations
Thesis
-
Improving Cardiovascular Disease Prediction
Author: Barda, N., 2020Supervisor: Bachmat, E. (Supervisor) & Davidovitch, N. (Supervisor)
Student thesis: Doctoral Thesis
Press / Media
-
Third BNT162b2 Vaccine Dose May Reduce Severe COVID-19 Outcomes
22/11/21
1 item of Media coverage
Press/Media
-
Third BNT162b2 Vaccine Dose May Cut Severe COVID-19 Outcomes
5/11/21 → 11/11/21
3 items of Media coverage
Press/Media
-
Third BNT162b2 vaccine dose may cut severe COVID-19 outcomes
5/11/21
1 item of Media coverage
Press/Media
-
Largest Real-World Study of COVID-19 “Booster” Vaccine Effectiveness A major study, conducted in collaboration with researchers from Harvard University, examined data on 728,321 individuals in Israel who received a third dose of the Pfizer/BioNTech vaccin
Noam Barda, Noa Dagan & Ran Balicer
2/11/21
1 item of Media coverage
Press/Media
-
Studie zur Booster-Impfung: So wirksam schützt die dritte Dosis
2/11/21
1 item of Media coverage
Press/Media
-
COVID-19 Vaccine Effectiveness Against the Delta Variant in Adolescents
Noam Barda, Noa Dagan & Ran Balicer
1/11/21
1 item of Media coverage
Press/Media
-
Booster vaccine dose effective in reducing severe covid-19-related outcomes: Lancet study
Noam Barda, Noa Dagan & Ran Balicer
1/11/21
1 item of Media coverage
Press/Media
-
Maßnahmen gegen die vierte Welle: Wie wirksam schützt die Booster-Impfung?
1/11/21
1 item of Media coverage
Press/Media
-
Largest Real-World Study Of Third Dose Of COVID-19 Vaccine Effectiveness
Noam Barda, Noa Dagan & Ran Balicer
30/10/21 → 31/10/21
4 items of Media coverage
Press/Media